Call for SPCs to be longer than five years
The five-year limit on supplementary protection certificates in the EU needs to be extended, said André Bourgouin of Ipsen Pharma last week
The EU introduced SPCs in 1992 to provide pharmaceutical
inventions with an extended period of protection to compensate
for the time it takes to obtain marketing approval. Under the
present system the combined market exclusivity of a patent and
SPC cannot generally exceed 15 years.
Speaking at a workshop at the AIPPI Congress in Paris,
Bourgouin said that since 1992 "the requirements of
registration agencies have considerably increased"...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.